Arcadia Biosciences (17D) Q2 2024 Earnings Report
DE:17D Q2 2024 EPS Results
- Actual EPS
- EUR 0.70
- Consensus EPS
- EUR 1.39
- Beat/Miss
- Missed by -EUR 0.69
- One Year Ago EPS
- EUR 0.55
DE:17D Q2 2024 Revenue Results
- Actual Revenue
- EUR 1.17M
- Expected Revenue
- EUR 850.63K
- Beat/Miss
- Beat by +EUR 318.76K
- YoY Revenue Growth
- -5.98%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/13/2024
- Time
- After Close
- Conference Call
- Tuesday, August 13, 2024
DE:17D Upcoming Earnings
Arcadia Biosciences's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:17D Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:17D Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | ―- | -0.76 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | ―-1.87 | -2.92 | 35.89% (+1.05) | |
| May 14, 2026 | 2026 (Q1) | ―-1.89 | 1.7 | -211.05% (-3.59) | |
| Mar 26, 2026 | 2025 (Q4) | -0.59-0.87 | -2.67 | 67.45% (+1.80) | |
| Nov 07, 2025 | 2025 (Q3) | -0.48-0.76 | -1.06 | 28.14% (+0.30) | |
| Aug 14, 2025 | 2025 (Q2) | -0.71-2.92 | 0.7 | -517.95% (-3.62) | |
| May 08, 2025 | 2025 (Q1) | -0.881.70 | -1.59 | 206.74% (+3.30) | |
| Mar 20, 2025 | 2024 (Q4) | -0.80-2.67 | -1.88 | -41.90% (-0.79) | |
| Nov 12, 2024 | 2024 (Q3) | -0.73-1.06 | -1.69 | 37.57% (+0.64) | |
| Aug 13, 2024 | 2024 (Q2) | 1.390.70 | 0.55 | 27.87% (+0.15) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
